Yılmaz Tonguç Utku, Kozan Ramazan
Acibadem University Atakent Hospital, Organ Transplantation Unit, Istanbul, Turkey.
Eren Hospital, General Surgery Unit, Istanbul, Turkey.
Clin Exp Gastroenterol. 2017 Nov 7;10:275-283. doi: 10.2147/CEG.S122784. eCollection 2017.
Dieulafoy's lesions (DLs) are rare and cause gastrointestinal bleeding resulting from erosion of dilated submucosal vessels. The most common location for DL is the stomach, followed by duodenum. There is little information about duodenal and jejunal DLs. Challenges for diagnosis and treatment of Dieulafoy's lesions include the rare nature of the disease, asymptomatic patients, bleeding symptoms often requiring rapid diagnosis and treatment in symptomatic patients, variability in the diagnosis and treatment methods resulting from different lesion locations, and the risk of re-bleeding. For these reasons, there is no universal consensus about the diagnosis and treatment approach. There are few published case reports and case series recently published. Most duodenal DLs are not evaluated seperately in the studies, which makes it difficult to determine the optimal model. In this study, we summarize the general aspects and recent approaches used to treat duodenal DL.
迪厄拉富瓦病（DLs）较为罕见，是由扩张的黏膜下血管糜烂导致胃肠道出血。DL最常见的部位是胃，其次是十二指肠。关于十二指肠和空肠DLs的信息较少。迪厄拉富瓦病的诊断和治疗面临诸多挑战，包括该病的罕见性、无症状患者、有症状患者的出血症状往往需要快速诊断和治疗、不同病变部位导致诊断和治疗方法的差异以及再出血风险。由于这些原因，对于诊断和治疗方法尚无普遍共识。近期发表的病例报告和病例系列较少。大多数研究未对十二指肠DLs进行单独评估，这使得难以确定最佳模式。在本研究中，我们总结了十二指肠DL的一般情况和近期的治疗方法。
